Lih-chu Chiou
TPQ 10051, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
α6GABAA receptors as novel targets for ADHD therapy: A proof-of-concept study in MK-801-treated juvenile mice.
Journal: European journal of pharmacology
Published: May 05, 2026
α6GABAA receptor-selective positive allosteric modulator as a novel therapy for fibromyalgia: A proof-of-concept study in mice modeling chronic widespread musculoskeletal pain.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: April 11, 2026
Intranasal dopamine: anatomical pathways, biological mechanisms and neuromodulatory potential.
Journal: Neuroscience and biobehavioral reviews
Published: March 18, 2026
Targeting the microbiome in pediatric migraine: gastrointestinal manifestations and the therapeutic role of Bifidobacterium longum.
Journal: Gut microbes
Published: December 27, 2025
Unravelling the role of cerebellar α6GABAA receptors in anti-tremor pharmacotherapies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 01, 2025
High-fat diet impairs the dendritic morphology of hippocampal CA1 pyramidal neurons in male but not female mice.
Journal: Frontiers in nutrition
Published: August 16, 2025
α6GABAA receptor positive allosteric modulators targeting trigeminal ganglia for preventing and aborting chronic periorbital allodynia and cephalic pain in both sexes: A mechanistic and comparative preclinical study.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 24, 2025
Hispidulin Isolated from the Leaves of Clerodendrum inerme (L.) Gaertn Suppresses Trigeminovascular System Activation in a Rat Model Mimicking Migraine.
Journal: Pharmaceutical research
Published: January 18, 2025
IUPHAR Review: Alpha6-containing GABAA receptors - Novel targets for the treatment of schizophrenia.
IUPHAR Review: Alpha6-containing GABAA receptors - Novel targets for the treatment of schizophrenia.
Journal: Pharmacological research
Published: December 03, 2024
The deuterated pyrazoloquinolinone targeting α6 subunit-containing GABAA receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy.
Journal: Frontiers in pharmacology
Published: June 19, 2024
Pivotal Role of Slitrk1 in Adult Striatal Cholinergic Neurons in Mice: Implication in Tourette Syndrome.
Journal: Annals of neurology
Published: April 07, 2023
Last Updated: 09/26/2026